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ECE.Inhlbltors provide an effective approach to pharmacologically block lho 
effects of endothelln in mnn, 
• Differential Effects of Protsmlne on Conductance 
and Resistsnce Arteries: Evidence of 
Hyperpolarlzlng Factor (EDHF) Release 
D,G, Cable, M,R, OeltJen, H.V, Scheff, M~yo Clinic end M~yo Foundaflen, 
Rochester, Minnesota, USA 
Background: Protamlno revorael of heparln may I~d to systemic hypoten. 
~lon eeeend~¢Y to endothellel nitric oxide (NO) mle~lse, Endothollum.derlvod 
hypsq0olerl;¢lng feeler (EDHF) Is a novel footer olessed by the ondothsltum 
The prOllOnt study compared the roleelln of vasoncllve substances from 
remten~a (100=,?.00 .m) and oonductnn~o erterles, 
Method# fmcl Results; Canine mnlstnnce comne~/~rtertes wan meunted 
In a vl~eesceple no.flow miomvassol system, end paired ~Imumflox coronnw 
arteries were studied in organ ehembem', both war0 oontragted with endotho. 
Iin.1, Pmfemlne (10-60 mgm/ml) predated rolexatlenn in both mlcmveasel 
end ¢ondu(~tence aderles (n '~ 10); maximum mlaxatlen wee 46,0 ;L 13,0% 
In re=lslnnce v~ 94,3 ~ 8.2% in conductance ndarles, Removal el the an. 
d0thellum ~boltshed relaxations to profemlno (n = B, P -. 0.05, ANOVA), 
tndomathn¢~ln (10 ~SM) did not attar rah~xetions; 462 ~. 8,5% vs 103.1 t 
?,.'1% (n = 6), L.NMMA (10 '~M) had na sheet In resistance aderies (575 
9,g%, n =, El) but attanunted ~olnxetlons incondu(~fan~e artertea (38,3 
12,0%, n ~ 8, P • 0,05), Tetmethylemmentum (chloride (TEA, 10 "~M), an 
inhibitor of ~DHF, abolished mlexattent~ n msts~en(~n arteries but had no 
effeC:t OI1 oonductenca rtertns (103,2 :t~ ~),0%, e ~ 0), Miomvease~s produced 
only mild Qentraotlens to prot0~mtno Inthr~ presence o1 TEA (max contraction 
24,5 ~l 11,4%, n ~ 6, P ,: 0,05), 
Conclusions: Pmtamlne sulfate ~eusos ond0thollum-depondent relax- 
allen of conductance adartes and mstMance edorles by different mecha- 
nisms; NO intense in large npicerdtnl vessels and EDHF release in mi. 
cmvessels, Thl~ Is the first description of EDHF release in response to 
pmtemine, As EDHF can be blacked with cnrdloplogi¢ arras1, protamine may 
generate malone1 Imbslan~:os in myocardial podus~en due to the dilation el 
conducten~'-e v ssels end concurrent constnctlon of resistance arteries, 
• Vascular Smooth Muacle Cell Proliferation 
Induced bythe Interactlon Between Serotonln 
(5H1") endMlldty Oxldlzed LOW Denslty 
Llpoproteln, laRevereed by 5HT= Receptor 
Antagonlst or Pertuasls Toxin 
S Keb~, R. P,~kela, 1". Katagm, C.R. Benedict. University of Texas, Houston. 
TX, USA 
Background: We have previously shown that mildly oxidized low density 
lipoprotoln (mox-LDL) induced vascula[ smooth muscle cell (VSMC) preht- 
eralion nnd this effect was potentiated by 5HT, We examined the pos~ible 
mechanisms for those effects. 
Methods: Growth arrested primary rabbit VSMC were incubated with 
different concentrations of LDL or mox-LDL in the presenco or absonce at 
pertussls toxin (PTX, 10 ng/ml) for 24 hrs, to,owed by incubation with 5HT (50 
.M) or with 5HT (50 ~iM) + 5HT~ receptor antagonist (LY281067, 10 ~=g/ml) 
for 24 hrS. Then 3H-thymtdine incorporated into the DNA was measured. 
Results: Beth LY 281067 and PTX reversed the mitogenic effect of 5HT, 
and the synergistic interaction between 5HT and LDL or mox-LOL on VSMC 
proliferatien. 
f ~ Control i 400 ~ SHT 






0 LDL 60~g/ml moxLDL 60%9/ml 
Conclusion: These results suggest that a 5HT2 receptor nntegonlst fLY 
281067) can prevent ff~o proliferative ffect of 5HT and its interaction with 
LDL or mox-LDL on VSMC at sites of vascular damage. 
~ Hlrudln Don Not Prevent Platelet ActlvaUon In 
Heperln Induced Thrombooytopenlc Syndromes 
D, Famed, J, Famed, L, Yang, D, Hoppansteedt. W, Jeske, S, Haas, 
H, Messmom, Loyola University Medical Center, Maywood, IL, USA, 
Technical University of Munich, Munich, Germany 
Rncombinenf hirudln (r.H) is approved for the anticoagulant management of 
pettante with heperin induoed thmmbocytopenia (HIT), De~pito the u~o of 
potent anticoagulant drugs the modnlity rate in patients with HIT and HIT 
with thrombosis romaine high, Initial sit=dies have indicated that o~o the 
antibody mediated salivation of pletelets has storied, himdin fails to inhib,t 
the process, To investigate this affect, blood was drawn from 30 human 
VOhlntoom in htmdtn (10 i~gtml) and 3.8% citrate, Whole bloocl impedomot~t 
nnd pletelot aggregation studies were carried out using a Ix~itivo HIT serum 
pool prepared from 20 clini(~elly established HIT positive p~tiente In both the 
~ltrated and hffudini=od blood systems a strong activation ot platelnts was 
observed, Hirudin also foiled to block the ATP release from ptatetets ulx~n 
the HiT sarum/hnpenn ec;tivetien. Similarly, in the flow ¢yt0mofno studies pa. 
tionts with established HIT syndrome c;olloctod in Citr~ted 0t himd!n exhibited 
strong ~atJvetion Supplementation ofg!ycopmtein lib/Ilia receptor mhibitom 
such as ReoPro, at sublherepo(~ti~ levels (05 i~g/ml), totally inhibited the 
HiT serum induced activation at platelats. The synlhcttc GP Ilbilga inhibitive 
else Inhibited tho activation of hirud=n nl~coagulated plat0tets. These obser. 
vations clearly suggest while hirudin may provide strong anticoagutation, it 
is of limited va!uo in tho acute phase of HIT. Antiplatelet drags such as GP 
lib/Ills inhibltora may be useful in the management el such cases 
~ Effects of Phytoestmgens on Precontrected 
Rabbit Coronary Arteries 
G.A. Fqgtmo, Y..Q. Lu, P. Coffins. Imperial Co#ego of Science, Technology & 
Medicine, NatPonal Heart & Lung In.qfihlto, London, UK 
Interest n the vascular properties of phytoostrogens ts mcmastr~j, however 
their effects or' coronary srtenas am largely unknown. We theretore investi- 
gated tho vasoactive properties of the phytoestrogons genislein (G), phlomtin 
(P) and biochanm (B) on rabbit coronary artenes in wtro. Epicardial coronaq/ 
artenal nngs of male and female rabbits were suspended in organ loathe 
lor measurement of changes in isometric tension. G (10, 20. 40 .mot~_) 
induced significant relaxation of coronary artenal nngs precontracted w~th 
potassium (30 raM) m a dose-dependent manner (mean ~: SEM: 13 ~ 1.48 
:'c 3 and 100 t 3% respectively, P .  0.01). as did P (5, 10. 20, 40 ~moL'L: 
11 ± 1, 30 ~ 2, 66 ~ 2, 97 ~ 3°o), and B (1.3. 10 and 30 .reel/L; 3 ~. 1, 
12 r I, 55 ~ 4, 103 ~ 3%). There were no differences between arteries 
from male or female rabbits, with or w~thout endothelium L-NAME and ln- 
doree[hacm did not affect phytoestrogen-induced mlaxahen in nngs with an 
intact ondothellum. Glibenclamide, banum chlonde and mehtylene blue had 
no effect on phytoestrogen-induced relaxation in nngs without endothelium. 
The specific estrogen-receptor antagonist ICI 182, 780 did no1 affect the 
coronary relaxation induced by any of the phytoestmgens. Calcium conoen- 
tralion-depende~,[ contraction curves (4, 3.,5.3. 2.5 and 2 .log M calcium) m 
K ~ depolarization medium were shifted to the right after incubation wilh G 20 
.mot/L (19.3 :~ 1, 47 ± 3.1, 62 ± 2.9, 81 ± 3.3 and 88.2 ± 43% contraclton 
respectively; P .  0.001) and 40 .mob'L (7.6 ± 0.6, 18.4 ¢ 1.2, 327 ± 3.2, 
602 ± 4 and 73.3 ~ 33% contraction respectively; P ~ 0.001) in nngs with- 
out endothehum compared to control (41.2 ± 2.7, 67 ~- 1,8, 81.8 ± 1.1.98 
1.3 and 100 ~- 0% contraclton respectively). Maximal contraction was also 
reduced. We have demonstrated that the phytoestrogens genistein, phlorelln 
and biochanin induoe signilicanl, endolhelium-independent relaxation in iso- 
lated rabbit ooronary arteries. The mechanism may involve antagonism of 
calcium channels. 
~ Ab¢iximab Inhibits Release of Platelet Granule 
Constituents 
MA. Mascelli. S.J. Marciniak, ET. Lance, R.E Jordan. Centocor, Inc.. 
Malvern, PA, USA 
The effect of abciximab tc7E3 Feb, ReoPro TM) on agonist-induced platelet 
granule release (PGR) was studied, Platelet rich plasma from normal donors 
i n = 3) was treated with abciximab for 5 rain at 37°C. The platelets were 
then stm~ulated with either TRAP or ADP and aggregation was monitored 
for 4 min. ATP release was monitored during aggregation by chemi-lumi- 
nescence. After aggregation, platelets were treated with inhibitora to block 
further release, then lhe ptasma was collected, t~-thromboglobulin (tt-TG) 
and plasminogen activator inhibitor 1 (PAl-l) plasma levels were measured 
